why choose us

Clinical Trials Search

Showing 13,030 of 132,366 result(s)
A Study Investigating the Effects of a Novel Mindfulness Approach on Frequency and Duration of Meditation and Self-Reported Stress and Mood in Generally Healthy Adults

Status: Completed

Condition: Health Knowledge, Attitudes, Practice

Interventions: Mindful consumption of tea along with an approximately 10-min guide

Date: 2023-04-13

Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

Status: Completed

Condition: FXI

Interventions: FXI-GalNAc-siRNA solution for injection

Date: 2023-04-13

Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

Status: Completed

Condition: Type 2 Diabetes

Interventions: 4 hours of prolonged SB

Date: 2023-04-13

A Randomized, Double-Blind, Placebo-Controlled Phase 2;3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

Status: Completed

Condition: COVID-19

Interventions: 30 mg twice daily for 5 days followed by 20 mg once daily for 5 days or until discharge (whichever is earliest).

Date: 2023-04-13

Nurse-Led Quality of Life Study-Phase I

Status: NOT_YET_RECRUITING

Condition: Quality of Life

Interventions: Comprised of three components: (1) establishment of clinical research nurse (CRN) and patient relationship, (2) assessment and monitoring of physical,

Date: 2023-04-13

Post-Transplant Cyclophosphamide in Patients Aged >;= 70 Years Undergoing Haploidentical Transplant

Status: Completed

Condition: Hematologic Malignancies

Interventions: Cyclophosphamide will be administered at 50, 40, 32, or 25 mg;k;d intravenous infusion (IV) continuously for two days starting 60-72 hours a

Date: 2023-04-13

Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness

Status: NOT_YET_RECRUITING

Condition: Normal Tension Glaucoma

Interventions: Glaucoma evaluation including structural and functional diagnostic testing at baseline and 3 subsequent follow-up visits over a period of 9 months

Date: 2023-04-12

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Status: COMPLETED

Condition: Seasonal Influenza

Interventions: Sterile liquid for injection

Date: 2023-04-12

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Status: Completed

Condition: Advanced Cancer

Interventions: KRAS G12C inhibitor

Date: 2023-04-12

Emergency Department-Initiated Medications for Alcohol Use Disorder

Status: NOT_YET_RECRUITING

Condition: Alcohol Use Disorder

Interventions: In the MAUD component, some participants will receive oral Naltrexone in the ED.

Date: 2023-04-12